# 119-hr-1476: PLASMA Act

119-hr-1476, PLASMA Act, is a 119th Congress bill sponsored by Rep. Hudson, Richard [R-NC-9] (R-NC); status introduced; PRIA reads it as touching household money (as of 2026-04-21).

- Canonical: https://policyrisk.com/legislation/119-hr-1476
- As of: 2026-04-21
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Bill: 119-hr-1476
- Congress: 119
- Title: PLASMA Act
- Status: introduced
- Introduced: 2025-02-21
- Sponsor: Rep. Hudson, Richard [R-NC-9] (R-NC)
- Cosponsors: 5
- Policy area: Health
- Touches household money: yes
- Last recorded action: 2026-04-21

## Summary

**Phased reduction of manufacturer discounts for plasma-derived drugs in Medicare Part D.** This bill would create a year-by-year phase-in that changes how the Part D manufacturer discount is calculated for plasma-derived products, with separate schedules for beneficiaries who have already spent on Part D drugs and those who have not, and exclusions for certain low-income subsidy beneficiaries and small manufacturers. - Medicare beneficiaries who have not incurred Part D drug costs would see the applicable manufacturer discount set at 99% in 2026, then step down to 98% in 2027, 95% in 2028, 92% in 2029, and 90% in 2030 and later. - Beneficiaries who have already incurred Part D costs face a longer phase-down that reaches 90% in 2030, 85% in 2031, and 80% in 2032 and later, creating different out-of-pocket dynamics by enrollee history. - Manufacturers of plasma-derived products marketed as of August 16, 2022 would have their discounted price calculated as a year-specific percent of the negotiated price, gradually reducing the required discount over time; the phase-in does not apply to certain drugs dispensed to low-income subsidy (LIS) beneficiaries and to specified small manufacturers.

## Cosponsors (5)

- Rep. Davis, Donald G. [D-NC-1] (D-NC), 2025-02-21T00:00:00.000Z
- Rep. Murphy, Gregory F. [R-NC-3] (R-NC), 2025-02-21T00:00:00.000Z
- Rep. Peters, Scott H. [D-CA-50] (D-CA), 2025-02-21T00:00:00.000Z
- Rep. Rouzer, David [R-NC-7] (R-NC), 2025-05-05T00:00:00.000Z
- Rep. Knott, Brad [R-NC-13] (R-NC), 2025-06-03T00:00:00.000Z

## Provisions PRIA read

- Phase-in for Medicare plasma drug prices: mixed, medium. If enacted, this would change how Medicare Part D counts prices for certain plasma-derived drugs. It would apply to drugs made from human plasma that were marketed by August 16, 2022. Starting in 2026, the counted price would be a set percent of the negotiated price for each fill. If you have hit t…

## Related bills

- 119-hr-9237: Take Care of America’s Veterans Act
- 119-hr-842: Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
- 119-hr-2725: Affordable Housing Credit Improvement Act of 2025
- 119-hr-3514: Improving Seniors’ Timely Access to Care Act of 2025
- 119-hr-1492: To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation…
- 119-hr-1151: Freedom to Invest in Tomorrow’s Workforce Act

## Sources
- [119-hr-1476 on Congress.gov](https://www.congress.gov/bill/119th-congress/house-bill/1476)

## Related
- [119-hr-9237: Take Care of America’s Veterans Act](https://policyrisk.com/legislation/119-hr-9237)
- [119-hr-842: Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage A…](https://policyrisk.com/legislation/119-hr-842)
- [119-hr-2725: Affordable Housing Credit Improvement Act of 2025](https://policyrisk.com/legislation/119-hr-2725)
- [119-hr-3514: Improving Seniors’ Timely Access to Care Act of 2025](https://policyrisk.com/legislation/119-hr-3514)
- [119-hr-1492: To amend title XI of the Social Security Act to equalize the negotiation period…](https://policyrisk.com/legislation/119-hr-1492)
- [119-hr-1151: Freedom to Invest in Tomorrow’s Workforce Act](https://policyrisk.com/legislation/119-hr-1151)
- [All bills in Congress](https://policyrisk.com/legislation)

Source: PRIA, https://policyrisk.com/legislation/119-hr-1476 (as of 2026-04-21).